-
Why 5 Of 6 UnitedHealth Analysts Are Cutting Forecasts After Q3 Earnings Release
Wednesday, October 16, 2024 - 12:18pm | 967Read More...UnitedHealth Group Inc (NYSE:UNH) reported on Tuesday upbeat earnings for its third quarter. The company reported its results amid an exciting earnings season. Here are some key analyst takeaways. RBC Capital Markets On UnitedHealth Group Analyst Ben Hendrix reiterated an Outperform rating while...
-
Teladoc Is Poised To Benefit From Growth In Telehealth, Baird Says In Upgrade
Monday, January 14, 2019 - 3:37pm | 448Read More...Teladoc Health Inc (NYSE: TDOC) shares are likely to be beneficiaries of several upcoming positive catalysts and an attractive valuation, according to Baird. The Analyst Analyst Matthew Gillmor upgraded shares of Teladoc from Neutral to Outperform and maintained an $80 price target. The...
-
Analyst: R1 RCM's Momentum Will Continue To Build Over Next Several Years
Monday, April 9, 2018 - 3:29pm | 348Read More...Hospital revenue cycle management company R1 RCM Inc. (NASDAQ: RCM) is uniquely positioned to benefit from accelerating demand environment for outsourced RCM, an analyst at Baird said. The Analyst Analyst Matthew Gillmor upgraded R1 RCM from Neutral to Outperform and increased his price target from...
-
Analyst: We're Downgrading Teladoc, But We Remain Very Bullish
Monday, September 18, 2017 - 11:03am | 419Read More...Analysts at Baird Equity Research no longer consider Teladoc Inc (NYSE: TDOC) to be a stock investors should necessarily be buying, although holders of the stock may not want to sell either. The firm's Matthew Gillmor downgrades Teladoc's stock rating from Overweight to Neutral with an...
-
HealthStream Shares Down 15% Recently; Baird Says Buy The Weakness
Wednesday, June 28, 2017 - 8:19am | 411Read More...Shares of HealthStream, Inc. (NASDAQ: HSTM) have lost around 15 percent after the provider of SaaS-based solutions provider to the healthcare industry confirmed it won't renew an agreement with Laerdal Medical, a key content and tech provider for Resuscitation products such a HeartCode and RQI...
-
The Street Could Be Underestimating Tailwinds For Press Ganey Holdings
Friday, June 24, 2016 - 11:14am | 239Read More...Baird’s Matthew Gillmor believes that Press Ganey Holdings Inc (NYSE: PGND) “is benefiting from broader growth drivers than simply CAHPS mandates, most notably the ongoing shift towards patient-centric care, and the rise of consumerism.” Gillmor maintains an Outperform rating on...
-
Baird Says 'Buy The Dip' In The Advisory Board Co, Upgrades To Outperform
Monday, August 17, 2015 - 8:43am | 336Read More...In a report published Monday, Baird analyst Matthew Gillmor upgraded shares of The Advisory Board Company (NASDAQ: ABCO) to Outperform from Neutral with a price target raised to $60 from a previous $55 following the stock's 20 percent decline after the company reported its second-quarter...
-
Addus HomeCare Corp. (ADUS) Maintains Outperform Rating
Monday, March 29, 2010 - 12:35pm | 114Read More...Analysts Whit Mayo and Matthew Gillmor at Baird have released an update on Addus HomeCare Corp. (NASDAQ: ADUS). Analysts believe that the state of disarray within Illinois is currently at its peak, but not getting better. According to analysts, on the positive side, the state has a new internal...
-
Universal Health Services (UHS) Price Target Raised To $41
Monday, March 1, 2010 - 10:03am | 159Read More...Baird analysts Whit Mayo and Matthew Gillmor reiterated their Outperform rating for shares of Universal Health Services, Inc. (NYSE: UHS) and raised their price target from $40 to $41. The Baird analysts said that guidance was positive and commented that, "adjusted for $0.18 in lost earnings from...
